Introduction: The EU legislation on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) aims to improve the level of human health and environmental protection which has also implications for occupational health and safety. The authors describe their own subjective definition of 'the ideal REACH world' from an occupational point of view as a desirable but unobtainable goal. The practicability of proposed REACH instruments is discussed in relation to specific constraints imposed by the legal framework itself and by contravention against and misinterpretation of the law. This is based on their experiences from within a competent authority.
Background
On 1 June 2007, the legislation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) came into force. REACH shall ensure the safe manufacturing, placing on the market and use of chemicals in the European Union. Registration aims to deliver data on hazards as well as descriptions of appropriate risk management measures (RMM). Evaluation comprises dossier and substance evaluation to ensure high quality of the registrations, and to remove data gaps and identify risks which need further regulation. Where risks are not being properly controlled, REACH provides two risk management measures: authorisation and restriction. To date (status May 2013), approximately 28,000 registration dossiers for substances were submitted and processed. The dossier evaluation is ongoing and 427 dossiers have been checked for compliance by the end of 2012 [1] . The substance evaluation has only started in 2012 and the first draft decisions on information requirements have been submitted to the registrants. Subsequent conclusions on the necessity of further risk management measures are still pending for most substances. The inclusion of substances in the candidate list
Introduction
The REACH regulation aims to ensure a high level of protection for the environment and human health as well as improving the function of the European trading and manufacturing markets [6] . The burden of proof that has been transferred to industry is to ensure that manufacturing, importing, distribution and use of substances does not cause adverse effects. This requirement applies to manufacturers, importers, distributors and downstream users within the supply chain. However, there is an overlap between the objectives of this legislation and those which already apply to protect workers from the risks of exposure to hazardous substances. REACH legislation applies without prejudice to workplace health and safety legislation (e.g. 98/24/EC, 2004/ 37/EC [7, 8] ).
The European Commission states that 'the arrival of REACH does not mean that employers' obligations are duplicated'. Employers have little more to do than review their risk management in the light of new information received and implement changes where necessary [9] . Thereby, REACH supports duties of employers under workplace legislation by improving for example the employers' risk assessment with additional information. Simultaneously, registrants' compliance with REACH in terms of appropriate and correct chemical safety assessment depends on input from knowledge about the properties of substances during their specific uses at workplaces. This information is already required by health and safety legislation and is part of the mandatory risk assessment for activities involving hazardous substances or processes.
One of the main aims for REACH implementation is to fill data gaps about possible hazards of chemicals manufactured, imported and used at community level. Information is compiled by the registrants and conveyed to the European Chemicals Agency (ECHA) where this information is collated. The obligation to register substances on their own or in mixtures manufactured and imported in the EU in quantities of one tonne or more per year will be completed on the first of June 2018 (for reference see Table 1 ). Then ECHA will have gathered the most extensive structured data collection on chemicals compared to anywhere else worldwide.
Results
In the following chapter, the authors describe the potential of the REACH instruments to improve occupational health and safety from their point of view by comparing it to the outlined REACH 'ideals'. The impact of the registration process, the chemical safety reports, proposed new exposure limits, the extended safety data sheets, and the substitution of SVHC on workers' health and safety are discussed in separate paragraphs.
General obligation to register and information requirements
In 'the ideal REACH world', all substances alone, or in mixtures, would be registered with a complete submission of valid and conclusive data (for reference see first column of Additional file 1). However, the registration processes under REACH do not require that each chemical substance in the workplace is covered and fully examined. The regulation generally exempts certain substances (e.g. non-isolated intermediates or waste) and sectors extensively regulated by other legislation (e.g. use as a biocide). Annexes IV and V of REACH list other substances excluded from registration either because this is deemed inappropriate or because sufficient information is available already.
A minimum tonnage of the manufactured or imported substance is necessary to trigger registration (1 t/a). The extent of mandatory information is reduced for on-site isolated (OSII) and transported isolated intermediates (TII). The toxicological information requirements increase with increasing tonnage bands only. From an occupational point of view, the profile of use of a substance and information about high exposures and wide dispersive professional uses would serve as more effective triggers. Read-across approaches and waiving of studies can also be justified. The registration requirements of REACH exclude chemical agents not intentionally produced or those present in the workplace for reasons not directly associated with occupation [7] .
In addition to the exemptions described above, the complexity of the regulation may make compliance a challenge. Some interpretations of the legal text are still subject to interpretation by the member states, ECHA, the Commission and the relevant bodies (RAC, SEAC) established under REACH. A summary of the more prominent drawbacks in the legislation relevant to the registration requirements is given in the second column of Additional file 1.
Based on the recent experience, reasons for noncompliance can be various. One example of noncompliance with legal provisions is that the exemptions from the registration requirements are not correctly understood. A very common problem is that the identity of the substance under consideration is often not clear or even incorrect [10] . Furthermore, the definition of intermediates and the term 'strictly controlled conditions' (SCC) is interpreted differently between the authorities and some companies [11] . To avoid unjustified toxicological tests, read-across approaches are made or certain toxicological tests are waived for unjustified reasons. Furthermore, the compilation of registration dossiers is performed very differently by each SIEF and different registrants may comply differently in a way not readily understandable for competent authorities or the downstream users. Non-compliance with the legal framework will occur when these assumptions, and estimations are not disclosed and/or not justified and when the technical dossier and the CSR are inconsistent. A non-exhaustive summary of these discrepancies is summarised in column 3 of Additional file 1.
Overall, the data requirements of REACH represent a meaningful step towards collecting structured information on all substances present in the European market. It will be the great challenge in the future to ensure the validity, usability and accessibility of these data.
Chemical safety report
In 'the ideal REACH world', the CSR for all hazardous substances would include adequate and conclusive exposure scenarios describing safe uses of the substance sufficient for workplace risk assessments (see column 1 of Additional file 2).
A CSR is obligatory for all registered substances used above 10 tonnes per annum and if the substance fulfils the criteria for hazards listed in Regulation (EC) No 1272/2008 (or PBT or vPvB), then exposure scenarios also need to be developed. These exposure scenarios describe the processes, operational conditions and RMM for the safe use throughout the whole life cycle for a substance. This is the centrepiece of REACH by which standards of health and safety at work can be raised, but the requirements of the CSR are challenging.
The registrant is obliged to describe the manufacture and use of the substance for all workplaces along the supply chain, even for processes the manufacturer does not control. Frequently, the supply chain is long and complex and a direct exchange with those end users who understand relevant workplace circumstances affecting exposure level is not possible. Various combinations of operational conditions and RMM can be chosen to achieve a safe use. The challenge is to choose and implement realistic parameters in accordance with workplace legislation. This demands sufficient input and experience from the downstream users to create a high level of abstraction; this was not required from manufacturers and importers before REACH.
Therefore, registrants commonly describe exposure scenarios on the basis of newly developed models which are based on more generic-tiered and conservative approaches. Mechanisms for upstream communication about new or deviating information on hazards and classification, impracticable parameters and the appropriateness of certain RMM are required under REACH, but are not as yet well established. A 'non-exhaustive' list of factors that limit the attainment of 'the ideal REACH world' at the workplace is summarised in column 2 of Additional file 2.
A list of factors that lead to non-compliance within the legal framework is given in column 3 of Additional file 2. One reason for non-compliance with the legal framework is that the whole life cycle of use for a substance is not covered. Maintenance work, cleaning of the facilities, and waste/recycling of the substance are uses frequently neglected from consideration. The evaluation processes show that in some cases, exposure scenarios are missing for common uses or that invalid exposure scenarios are provided. Hazardous transformation and/ or degradation products from which a risk arises are not assessed in the scenarios describing the use of their precursor substances. The reasons for these deviations are usually based on missing or inefficient consultation or missing or unsuitable feedback from downstream users during the boundary conditions that applied for the first registration deadline in 2010. Further non-compliance can be attributed to registrants' failure to realise that the REACH regulation applies without prejudice to the workplace health and safety legislation. For example, the hierarchy of measures defined under STOP principle (substitution, technical measures, organisational measures, and personal protective equipment) has to be implemented [7] . Whilst an assessment of substitutes is not required of the REACH registrant, they are expected to follow the TOP principle whereby the use of personal protective equipment to reduce exposure to a hazard is further down the control hierarchy and other measures of control have to be considered first. The permanent use of personal protective equipment is not an adequate means to minimise the risk of exposure in the long term, and is not considered acceptable in most cases; especially in cases technical measures could be applied instead.
Another aspect of this process is that registrants need to assess substances alone and not in the context of other substances in a mixture. An assessment for a substance in all existing mixture combinations would be impossible for the registrants. Whilst other potentially hazardous substances cannot be considered in undertaking the REACH registration of a specific substance these do need to be included when duty holders conduct a risk assessment of the workplace under existing health and safety legislation. In the context of workplace legislation, the definition of hazardous substances is wider than the scope of REACH and comprises substances classified according to the Classification, Labelling and Packaging (CLP) legislation and those that do not meet the CLP classification criteria but may be a hazard under workplace circumstances [7] .
REACH requires manufacturers and importers to describe safe uses of their substances in the supply chain for the first time. This task is challenging. Whether the REACH process can deliver its benefits for occupational health and safety mainly depends on the efforts of industry and the value of the feedback from downstream users.
DNELs -new exposure limits?
In 'the ideal REACH world', limit values would apply to all hazardous substances to inform control actions (for reference, see column 1 of Additional file 3).
At the EU level, two concepts for deriving occupational exposure limit values exist. The first being binding occupational exposure limit values (BOELVs) for which member states are obliged to derive national limit values equal to or lower than the BOELV [7, 8, 12] . For their derivation, toxicological information, socio-economic information and technical feasibility factors need to be taken into account [13] . The second set are the indicative occupational exposure limit values (IOELVs) [14] [15] [16] for which member states are obliged to derive national limit values that can either be higher or lower than these IOELVs. These limit values were based on consideration of evidence for an impact of the substance on health [13] ; currently 5 BOELVs and 112 IOELVs have been set. For both sets of limits, the focus is on airborne exposure rather than dermal contact. The progress with the EU standards can be compared to historical national exposure limits. For example, in Germany, occupational exposure limit values for inhalation have been derived for 386 substances [17] .
Annex I of the REACH regulation introduces new health-based reference values above which humans should not be exposed. This level of exposure is the derived no-effect level (DNEL). As there are different types of exposure and target groups (worker, consumer), different types of DNELs are defined. For the workplace, eight types of DNELs are relevant (see Table 2 ).
As a rule for risk management, the lowest inhalation DNEL and the lowest dermal DNEL are considered the Inhalation most relevant. DNELs can only be derived when quantitative dose-response relationships for the adverse effects under discussion exist. For most carcinogenic and mutagenic effects mechanistic considerations reveal a lack of a threshold, and therefore, the derived minimal-effect level (DMEL) shall be derived. However, this parameter is not defined in the legal text, but only in the guidance documents [13] . In Germany, a newly developed riskbased concept for carcinogens is currently under evaluation [18] . Three risk bands and respective tiered risk management measures were agreed on by employees' and employers' representatives and authorities. But across the EU community, actors subject to REACH are left to make the decision which risk reference values to apply to carcinogens and mutagens for which a threshold effect level cannot be determined. Therefore, there is a strong need to implement a politically agreed risk value for these substances of high concern.
In an attempt to gain an overview of existing DNELs and DMELs and to assess their impact on occupational health and safety, the data from ECHA's publicly accessible database [19] were analysed.
After the first registration deadline on December 2010, approximately 5,000 individual substances were registered including intermediates (OSII, TII) and low tonnage substances (1 to 10 t/a) for which no DNELs and DMELs were derived. The analysis revealed 1,728 substances with unambiguous identity for which 4,765 DNELs and DMELs for workers were derived. Number and type of DNELs and DMELs depend on the identified uses and exposure scenarios submitted with the registration of a substance. In ECHA's public database, the DNELs and DMELs are presented deep within the structure. An easily accessible and searchable source which specifically provides DNELs and DMELs for registered substances was made available by the German social accidence insurance [20] . It is not possible to conclude whether all DNELs and DMELs required by REACH have been derived because the number of DNELs and DMELs depend on the hazard, the existing exposure and the approach chosen.
Furthermore, when comparing publicly available data with the chemical safety report which is not publicly accessible, DNELs and DMELs can sometimes be found in the latter document only. Irrespective of these issues, the number of existing DNELs and DMELs is significantly higher than the number of BOELVs and IOELVs that had been introduced at community level before REACH came into force and higher than the number of national, e.g. German, OELs [17] . DNELs are not workplace limits that are legally binding and have not been through a rigorous process of setting. They can only act as guidance to assess whether the protection measures taken are adequate.
The Guidance Document R.8 describes the derivation of DNELs [13] . In principle, DNEL derivation and OEL derivation (at least in Germany) follow the same guidelines in extrapolation from experimental results onto the workplace exposures limits. Figure 1 shows that approximately 60% of all DNELs were derived for chronic systemic exposure routes. Since chronic DNELs are in principle lower than the corresponding acute DNELs, it is rather uncritical to refer to chronic DNELs for acute exposure, too. Hence, the derivation of chronic DNELs will -in terms of management strategies for occupational health and safety -also be preventive to acute effects.
The focus of DNELs seems to be primarily on systemic effects. Hence, an underestimation of local effects (corrosion, irritation and sensitisation) cannot be excluded at this point, and therefore, these effects seem to be insufficiently considered in the chemical safety assessments.
The analysis of DNELs also revealed that only for a few substances, different registrants derived different DNELs. Figure 2 shows that the difference between registrant's DNELs ranges in the majority of cases between factors of 1 and 5, but in a few cases, the deviations are more pronounced. Table 3 displays the example of a single substance for which three registrants derived three different values. The DNEL of Registrants A and B diverge by a factor of 16.6 and registrants C submitted a DMEL instead of a DNEL. The exemplary substance is not classified as a carcinogen or mutagen and therefore there is no necessity to derive a DMEL. Deriving a DMEL for such a substance is simply wrong. It also shows that confidence in DNELs derived by registrants might be questioned. However, the authors do not know whether a more systematic examination of the data would reveal a greater prevalence of presumably incorrect DNELs and DMELs.
Although this discrepancy between DNELs in registrations is obviously present, it does not negate the legal framework but limits the anticipated REACH 'ideal' for effective control of workplace exposures. Downstream users of these registrants are confronted with different reference values which might then lead to different RMM being implemented. Stricter RMM might lead to competitive disadvantages. Further reasons for noncompliance in this area can be found in column 2 of Additional file 3.
In the context of REACH, DNELs and DMELs are the reference values that have to be compared with the values derived for exposure. Uses of a substance that result in a risk characterisation ratio (RCR -quotient of exposure level and effect level) below 1 are considered to be safe, while RCR > 1 will require additional measures to be prescribed in the exposure scenario in order to define an acceptable risk.
Overall, the implementation of the REACH regulation resulted in an increased number of benchmarks to define harmful exposure levels. In addition, working practices that are obviously unsafe (e.g., showing RCR much larger than 1) may not be reported as an 'identified use' but as a 'use advised against'. By this means some critical uses of hazardous substances might decrease. Obviously, these values are only helpful, if properly derived on the basis of the most robust and latest data. The authors want to point out that although DNELs and DMELs do not directly entail legal consequences, with respect to workplaces, they will be and are regarded as an additional reference value for risk assessment [21] .
Communicating information via (extended) safety data sheets
In 'the ideal REACH world' the (extended) safety data sheet would provide information that is clear and relevant to workplace situations and would represent a transfer from the registrant to the recipient and vice versa (for reference see column 1 of Additional file 4).
The safety data sheet (SDS) shall enable the recipient to take the necessary measures to protect the health of workers and the environment. Under current health and safety legislation the SDS is the main information source for employers undertaking risk assessment involving hazardous substances. (7) of REACH require those who prepare a CSR to place the relevant exposure scenario in an annex to the SDS. This SDS is called extended safety data sheet (eSDS).
The (e)SDS links legislations of placing chemicals on the market and worker protection. A CSR has to be provided for specific registered substances only; however, in workplaces, mixtures of substances are commonly used [22] . Therefore, most employers will be confronted with exposure scenarios that apply only for a minority of their workplace chemicals. It is the formulator as the first downstream user who mainly has to deal with the problem of utilising the exposure scenarios provided in the eSDS, and to consolidate them along with relevant information into SDSs for their products. Exposure scenarios, especially those for the workplace, are likely to be numerous and specific to bespoke processes and business practices. For a widely used solvent with for example 10 identified uses often as many as 80 different contributing exposure scenarios are compiled. Many of these exposure scenarios may be quite similar and differ only in minor details. It is difficult to consolidate all of this information into a handful of relevant specifications for safe handling as required in Sections 7 and 8 of the SDS. This is an important issue as the SDS is intended to be a clear and concise document, which takes into account the specific needs and knowledge of the user group. The new requirements concerning communication in the supply chain and downstream user compliance are sources of non-compliance with REACH (see a nonexhaustive summary in column 3 of Additional file 4). As a rule, the attached exposure scenarios are neither available in a harmonised and structured format nor aggregated into predictive descriptions that are representative for the majority of workplaces at the moment. These problems clearly show the need to create a common format for the exposure scenarios and to clearly define and structure the relevant information that has to be transferred from the CSR to the exposure scenario annexed to the SDS. In addition, even though it is legally acceptable to attach all exposure scenarios (see column 2 of Additional file 4), recipients would benefit more if suppliers provided only those exposure scenarios relevant to the recipient.
On the other hand, the recipient, be it the formulator or the end user, has to check whether he complies with the conditions set out in the exposure scenario received with the substance. This is especially important in cases downstream users receive a generic exposure scenario and need to decide whether this is sufficient for a specific workplace. With respect to REACH, they are obliged to apply, as a minimum, the conditions of the exposure scenario communicated to them. With respect to worker legislation, downstream users have to identify further workplace-specific conditions and hazards in their risk assessment. It is essential that inadequate exposure scenarios are amended to enhance their value to users of that information. In order to achieve this, recipients need to give feedback to their supplier(s) on the appropriateness of RMM, occupational conditions and process parameters as well as the readability of the eSDS. The quality of the CSR, especially the exposure scenarios, will improve when the knowledge of end users is fully integrated to ensure relevance of this information. For example, do exposure scenarios point to practical and relevant control measures, or do they point to measures that are potentially in conflict with other elements of health and safety legislation? REACH provides two mechanisms to address the appropriateness of exposure scenarios: the option to make details of a downstream use known to the registrant to enable him to prepare appropriate exposure scenarios (articles 37(2) and (3)) or the option of upstream communication of inappropriate RMM in received exposure scenarios (Article 34).
The first two REACH registration phases delivered data that should have increased the quality of SDS [23] . At the moment, this envisaged improvement is hindered by lack of experience, the use of instruments still under development, especially for exposure assessment (Eteam project [24] ), lack of structured templates and lack of easily exchangeable formats for information exchange (under development: ESComXML) [25] . The rush to be 'REACH-compliant' to fulfil the minimum requirements of registration of dossiers on schedule and to prepare (e) SDS [23, 26] might have led to the submission of incomplete and incorrect registration dossiers and the recommendation of inappropriate RMM. The focus of industry may shift to improving the quality of the registration dossiers and SDS when these more time-consuming processes are completed. Whilst the eSDS is still at an early stage of implementation, the authors of this paper conclude that cooperation and improved awareness within the supply chain can improve the foundation for the safe handling of chemicals at workplaces.
Substitution of substances of very high concern
In 'the ideal REACH world', all substances of which the use comprises a risk would be identified and substituted (see column one of Additional file 5). In focussing solely on occupational health and safety, the authors do not agree with the identification of SVHC substances based only on their hazard classification without risk characterisation of the substance as applied at the moment. However, the legal text of REACH is not so specific. SVHC by definition of the REACH regulation are those substances that are included in the candidate list for authorisation on the basis of their classification as CMR, their PBT or vPvB properties or of their equivalent level of concern (ELC) [27] . In 2010, the EU commissionaires Tajani and Potočnik asked the Member State Competent Authorities and ECHA to intensify their work to accomplish the inclusion of 136 substances into the candidate list. This goal was hardly achieved and therefore the European Commission initiated a roadmap of SVHC stating that until 2020, the candidate list should contain all relevant substances [28] .
The purpose of the candidate list can be interpreted quite differently. The hazardous properties of a substance alone are sufficient for the SVHC identification, and at first sight, filling the candidate list is straightforward. This approach can prevent the use of an equally hazardous substance as an alternative. However, experience from workplace risk assessments demonstrates that considering the hazard status alone without considering the risk likelihood of exposure can be meaningless. Consequently, when the risk is foreseeably low and can be controlled by suitable RMM, the authors are of the opinion that resources would be better allocated to activities tackling substances associated with high risks.
The process of identifying SVHC is well under way and constitutes a clear incentive for the continuous elimination of CMR substances. However, CMR substances have always been in the focus of regulation [8] and are a significant, but not the most frequent problem in workplaces. Currently, the SVHC process is very focused on CMR substances and PBT/vPvB substances. So far (status December 2013), only seven substances (respiratory sensitisation, endocrine disruption) out of 144 were identified as SVHC due to article 57f where identification was of 'equivalent level of concern' to the related SVHC. From an occupational safety point of view, it could be argued that substances with less pronounced hazard properties, but high risks for exposure and harm (e.g. substances that are skin sensitising or STOT RE) might also be subjected to SVHC identification and authorisation. In particular, substances causing dermal allergies might be candidates for such considerations because of the increasing frequency and gravity of skin diseases as observed at a community level [29, 30] . Nevertheless, this definitely needs a case by case investigation and discussion of every single substance.
Substances listed in the candidate list may be prioritised by ECHA and the member state committee (MSC) for inclusion into Annex XIV of the REACH regulation. The prioritisation approach developed by ECHA [31] considers the inherent properties, the volume and the wide-dispersive use of a substance. Each criterion is divided into categories of different scores (initially published values, see Tables 4, 5 and 6 ). These were developed in a way that the criteria are weighed with 18%, 41% and 41%, respectively. The recommendation criteria do not give priority to substances relevant for worker exposure. The maximum score for inherent properties can only be achieved in case of substances that are PBT and vPvB or PBT with T being nonthreshold C or M. Giving the highest score to environmental hazards was an attempt to promote the prioritisation of this specific concern since most of the substances with PBT and/or vPvB properties have low volumes and have proven to be hardly prioritised. According to the guidance given by ECHA [32] , the 'wide disperse use of a substance is characterised by the assumption that the substance is used by consumers or by many users in the public domain, including small, nonindustrial companies'. Consequently, the high scoring values for wide-dispersive use generally gives priority to substances largely found in consumer products. From our point of view, promotion of substances that are relevant for worker exposure (e.g. widespread use: 'Uses taking place at many places, which however do not result in significant releases of a substance, may be considered only as 'widespread' but not as 'wide-dispersive' [33]) is missing. The following fictional example using revised but not yet published scores shall elucidate that there are scenarios that will clearly prevent a fast and necessary promotion from the candidate list to Annex XIV of a substance for which a risk has been identified: Assuming to have a substance toxic to reproduction, that is produced in volumes of 10 to 100 t/a and used community-wide in a non-diffuse manner in 100 sites would gain a score of 6. Assuming further that more than 1,000 workers are exposed and limit values are exceeded, further legislation is deemed appropriate from occupational safety and health point of view. Since the criteria do not take the risk into account, the substances would not be prioritised for a long time due to a low score. From our current experience, we would at least question effectiveness as well as efficiency of the current scoring system in relation to occupational health and safety. Eventually, the commission will decide on the inclusion in Annex XIV which prohibits all uses of the substance unless authorisation for a specific use is granted. An application date and the latest date of use ('sunset date') will be announced and industry can decide whether to apply for authorisation or switch to suitable alternatives. Taking account of ECHA's capacities and the undefined period of time for comitology to take place, only a limited number of SVHC can be included into Annex XIV at a time. The REACH legal text does not specify if and when prioritisation from the candidate list into Annex XIV will take place which causes great planning uncertainties for industry. Authorisation shall be granted if the risk to human health or the environment is demonstrated to be adequately controlled (article 60(2)). If adequate control cannot be demonstrated, authorisation may only be granted if it is shown that socio-economic benefits outweigh the risks (article 60(4)).
Substitution is always the preferred option, although it is not always technically feasible -either by exchange of the substance or by alternative technical processes, or by a combination of these options. Considerations on suitable alternatives include an assessment whether the substitution will result in reduced overall risk and whether the alternatives are technically and economically feasible for the applicant. When there are no suitable alternatives, authorisation may be granted if the socio-economic benefit outweighs the residual risks from using the substance. The authors want to note that only the future will show whether applicants with either few or many resources will be treated equally upon authorisation applications. It will be interesting to see if and how the committee for the socio-economic assessment will tackle this topic.
In response to REACH implementation, industry reacted proactively in some cases and even tried to phase out substances that fulfil the criteria for inclusion into the candidate list for Annex XIV (personal communication with industry). From this perspective, the authors consider the impending authorisation process based on the hazard status an effective instrument to drive a focus on substitution. Whether such substitution will result in the desired reduction of overall risks needs to be examined. Sometimes, little is known about the hazards and risks associated with alternative chemicals. Even less is known about products imported into the European Union that contain the same substances.
In conclusion, based on the authors' knowledge and experience, the authorisation process is one of the most promising tools under REACH by which improvement of environmental and human safety and health can be made driving the process of substitution. However, this prioritisation is not in the authors' view being efficient to improve occupational health and safety.
Discussion
In the authors' experience, the first years of REACH were characterised by learning-by-doing for the industry, the competent authorities, ECHA and non-governmental organisations. Since all of the relevant processes have started, a first résumé can be drawn. In this paper, the authors have assessed progress with implementing the REACH instruments, highlighting promising developments, as well as challenges and limitations particularly for occupational health and safety:
Have the REACH instruments improved the health and safety of workers in companies?
REACH aims to deliver structured and accessible information on chemicals, e.g. toxicological and physicochemical information to achieve adequate classification and labeling, or DNELs. Relevant data are publicly available in the ECHA database. Classification, information on the uses, operational conditions and relevant risk management measures are communicated via SDS. The understanding of manufacturers and importers on the life cycle of their substances has also increased. Bidirectional communication and collection of knowledge about hazardous substances in use have been achieved in some cases ensuring more reliable data within the supply chain. These achievements are clearly a large step From the authors' point of view, the transfer of the burden of proof to the manufacturers and suppliers of chemicals has increased their efforts to tackle unknown and neglected risks from hazardous substances. However, a gap in the application of these processes to improve standards of occupational health and safety remains. There are a number of caveats that have to be applied and which have been summarised in Additional files 1, 2, 3, 4 and 5 (columns 2, respectively). These current limitations should provide a focus to further develop practical means for duty holders to apply REACH in the context of occupational health and safety.
Anyway, 'the ideal REACH world' in which only adequately controlled uses exist in relation to occupational health and safety (reflected in Additional files 1, 2, 3 and 4 (columns 1, respectively)) can and will not exist. The described picture is an unobtainable goal and serves as an orientation for further efforts.
Which obstacles persist?
In article 1 of the REACH regulation, the goals are set out to ensure a high level of protection of human health and the environment based on the precautionary principle, whilst improving free trade and circulation of substances on the internal market enhancing both competitiveness and innovation [27] . The combination of these objectives in REACH is challenging: Global competitiveness and adequately controlled risks can be conflicting interests. Obviously, the substitution of a SVHC comprising high risks is desirable, but not always immediately technically feasible. Furthermore, protection of the environment, the consumer and the worker can be competing objectives in relation to obligations stipulated in the law and its interpretation. Meeting at least one of these other obligations may present obstacles to improve occupational health and safety standards. One example is the definition of criteria for the prioritisation of SVHC for inclusion in Annex XIV which may place substances of high risk for the workplace on a holding position on the candidate list.
These challenging objectives and the broad goals of the REACH regulation are not the only sources of problems for implementing this legislation in the workplace. The shifting of the burden of proof for the protection of human health and the environment from the regulator to the industry was challenging and time-consuming because industry had to adapt to these concepts and introduce suitable processes. It is important that REACH processes leave room for individual solutions as duty holders and the companies they represent differ greatly in their size, resource base and access to expert knowledge that will be required to address some aspects of the legislation. But this simultaneously leads to drawbacks. For example, the process for preparing exposure scenarios is not prescribed in the legislation and so various approaches have been developed. This is a challenge for the recipients of the SDS coping with different formats.
These principles and concepts will persist in the future and will hinder the implementation of 'the ideal REACH world' in relation to occupational health and safety. In addition to the complexity of the legislation, scientific limitations regarding occupational exposure to some substance will also persist.
How can implementation problems be overcome?
Despite persisting problems, the authors are optimistic that not all obstacles will remain. The interpretation of the legal text will become more consistent. To increase compliance with legal obligations and provide further clarification support is offered at national and community level in the form of guidance and immediate helpdesk support by authorities and industrial organisations. This support is constantly adapted to the increasing knowledge on the interpretation of the legal text and to the common working practice. The industrial organisations seem to increase their efforts of support and thereby gain more importance for duty holders. A good overview on these industry sponsored activities can be found on the Cefic website [34] or for a special focus on exposure scenarios, in the exchange network on exposure scenarios (ENES) [35] .
Guidance is also being improved based on knowledge from the workplace assessment of exposure and this is being triggered by on-going evaluation processes performed by ECHA and the member states. Evaluation is one instrument that will reveal and reduce data gaps and should reduce legal non-compliance of the type outlined in Additional files 1, 2, 3 and 4 (columns 3, respectively). When a registration dossier is submitted to ECHA, it generally passes only an IT-supported accordance check which might not reveal incorrect information. A closer look at the registration dossiers is then carried out by ECHA on 5% of the registrations via a formal dossier evaluation. The focus so far has been on the evaluation of toxicological assessment and environmental questions. ECHA's current approach shifts to a targeted approach, namely selecting specific points of concern. Considering occupational health and safety, it is desirable to enhance the emphasis on exposure and risk management in the future. However, the evaluation of exposure scenarios is difficult at the moment and in most cases has to be done manually. Exposure scenarios are submitted in the CSR in PDF format and are not part of the registration dossier that is submitted in a structured and IT-searchable format (IUCLID) [36] . ECHA provides an IT-application named CHESAR [37] that is linked with IUCLID and able to generate the CSR and exposure scenarios for communication in the eSDS in a structured, harmonised and efficient way.
The first results of the evaluation processes show that some exposure scenarios and risk management measures from the first registrations may be very schematic, incomplete, inadequate, and/or overprotective and may not respect the hierarchy of risk management measures. ECHA's current approach in dossier evaluation shifts to a targeted approach, namely selecting specific points of concern. Considering occupational health and safety, it is desirable to enhance the emphasis on exposure and risk management in the future.
Which REACH instruments need to deliver their full potential?
While the registration, dossier evaluation and improvement of communication along the supply chain are progressing, other REACH processes have just started.
The substance evaluation (SEv) process involves an in depth analysis of a carefully selected set of substances (e.g. missing information about substance properties reflecting risks or exposure-related information) and highlight where there is a need for further risk management or regulation. These data gaps can be addressed by ECHA's decision on additional requirements on the registrant. In those cases where the SEv process identifies a need for further regulation, authorisation requirements or restrictions might be initiated. Only a few substances have been taken through the SEv process to date, and so the value of this new instrument will only become clear in future. The first results of the evaluation processes show that some exposure scenarios and RMM from the first registrations may be very schematic, incomplete, inadequate, and/or overprotective and may not respect the hierarchy of RMM. The SEv is a promising instrument to identify work-related risks and to decide if further regulation is needed.
The process of authorisation for SVHCs will achieve its full potential in promoting substitution of hazards when companies proactively change formulations and downstream users demand that suppliers avoid using SVHCs in their products. The process of identifying SVHC and their prioritisation within Annex XIV leaves room for improvement in assessing risks of exposure to these substances in the occupational setting. Granted authorisations cannot be evaluated so far as no decision on an application has been made.
